X0306 4 2014-04-15 0 0001328143 Adamas Pharmaceuticals Inc ADMS 0001129541 MDV VII LP 3000 SAND HILL ROAD SUITE 3-290 MENLO PARK CA 94025 0 0 1 0 0001410787 MDV IX LP 3000 SAND HILL ROAD SUITE 3-290 MENLO PARK CA 94025 0 0 1 0 0001564546 Seventh MDV Partners, L.L.C. 3000 SAND HILL ROAD SUITE 3-290 MENLO PARK CA 94025 0 0 1 0 0001573991 Ninth MDV Partners, L.L.C. 3000 SAND HILL ROAD SUITE 3-290 MENLO PARK CA 94025 0 0 1 0 0001027621 FEIBER JONATHAN D 3000 SAND HILL ROAD SUITE 3-290 MENLO PARK CA 94025 0 0 1 0 0001250354 SCHOENDORF NANCY J 3000 SAND HILL ROAD SUITE 3-290 MENLO PARK CA 94025 0 0 1 0 0001605837 MDV ENF VII (A), L.P. 3000 SAND HILL ROAD SUITE 3-290 MENLO PARK CA 94025 0 0 1 0 0001605838 MDV ENF VII (B), L.P. 3000 SAND HILL ROAD SUITE 3-290 MENLO PARK CA 94025 0 0 1 0 0001605840 MDV VII Leaders' Fund, L.P. 3000 SAND HILL ROAD SUITE 3-290 MENLO PARK CA 94025 0 0 1 0 Common Stock 2014-04-15 4 C 0 1029984 A 3772686 I MDV VII LP, nom for MDV VII LP, MDV VII Leaders' Fund LP, MDV ENF VII (A) LP, and MDV ENF VII (B) LP Common Stock 2014-04-15 4 C 0 511328 A 511328 I MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF Common Stock 2014-04-15 4 P 0 265150 16.00 A 265150 I MDV VII, L.P. Common Stock 2014-04-15 4 P 0 6043 16.00 A 6043 I MDV ENF VII (A), L.P. Common Stock 2014-04-15 4 P 0 3146 16.00 A 3146 I MDV ENF VII (B), L.P. Common Stock 2014-04-15 4 P 0 25661 16.00 A 25661 I MDV VII Leaders' Fund, L.P. Series AA Convertible Preferred Stock 2014-04-15 4 C 0 1029516 0.00 D Common Stock 1029516 0 I MDV VII LP, nom for MDV VII LP, MDV VII Leaders' Fund LP, MDV ENF VII (A) LP, and MDV ENF VII (B) LP Series AA Convertible Preferred Stock 2014-04-15 4 C 0 468 0.00 D Common Stock 468 0 I MDV VII LP, nom for MDV VII LP, MDV VII Leaders' Fund LP, MDV ENF VII (A) LP, and MDV ENF VII (B) LP Series AA-1 Convertible Preferred Stock 2014-04-15 4 C 0 511328 0.00 D Common Stock 511328 0 I MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF IX, L.P. Upon the closing of the Issuer's initial public offering, each share of Series AA Preferred Stock automatically converted into 1 share of Common Stock for no additional consideration and had no expiration date. Upon the closing of the Issuer's initial public offering, each 1000 shares of Series AA-1 Preferred Stock automatically converted into 1 share of Common Stock for no additional consideration and had no expiration date. Seventh MDV Partners, L.L.C. is the general partner of (i) MDV VII, L.P., as nominee for MDV VII, L.P., MDV VII Leaders' Fund, L.P., MDV ENF VII(A), L.P, and MDV ENF(B), L.P., (ii) MDV VII, L.P., (iii) MDV ENF VII (A), L.P., (iv) MDV ENF VII (B), L.P. and (v) MDV VII Leaders' Fund, L.P. (the "MDV VII Funds") and has sole voting and investment power over the shares. Jonathan Feiber ("Feiber") and Nancy Schoendorf ("Schoendorf") are managing members of Seventh MDV Partners, L.L.C. Feiber and Schoendorf may be deemed to share voting and investment power over the shares. Each Reporting Person disclaims beneficial ownership of the shares held by the MDV VII Funds except to the extent of any pecuniary interest therein. William Ericson ("Ericson"), a general partner with Mohr Davidow Ventures, may be deemed to indirectly beneficially own the shares affiliated with the MDV VII Funds. Ericson is a director of the Issuer and, accordingly, files separate Section 16 reports. Ninth MDV Partners, L.L.C. is the general partner of MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF IX, L.P. Ericson and Feiber are Managing Members of Ninth MDV Partners, L.L.C. Feiber and Ericson may be deemed to share voting and dispositive power over the shares held by MDV IX, as nominee for MDV IX, L.P., and MDV ENF IX, L.P. Each Reporting Person disclaims beneficial ownership of the shares held by MDV IX except to the extent of any pecuniary interest therein. Ericson is a director of the Issuer and, accordingly, files separate Section 16 reports. The shares do not have an expiration date. Brett A. Teele 2014-04-16